Plain-English translation of NCT05178966 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bipolar Disorder research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a one-day psychoeducation program called BP OneDay that brings together patients with bipolar disorder and their caregivers to learn about the condition, how to manage it, and how to reduce stress and stigma. The program is designed to fit into busy schedules—it's just one day instead of a longer course. Researchers want to see if this shorter program can help caregivers feel less burdened and help patients better understand and manage their bipolar disorder.
Bipolar disorder affects not only the person diagnosed, but also their loved ones and caregivers, who often experience significant stress and burden. While longer education programs have been shown to help, many people can't attend because of work, family, or other obligations. This trial exists to test whether a condensed, one-day version can deliver the same benefits in a way that actually fits into people's real lives.
You likely qualify if…
You likely don't qualify if…
If you are chosen for the study, you and your caregiver will attend three visits: an initial intake appointment, the one-day psychoeducation program, and a follow-up visit about a month later. During the program, you'll learn about bipolar disorder, how to manage it together, and ways to reduce stress and stigma. If you're assigned to the waiting list group instead, you'll receive your usual care and have the option to attend the program after the study ends.
AI-generated summary from trial data · Jun 8, 2026 · Not medical advice
France